Psyence Biomedical Ltd.
Psyence Biomedical Ltd. (PBM) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · PBM · as of Sep 30, 2025
Ownership Breakdown
6
Institutional Holders
$763,723
Total Inst. Value
▲ $138,450 vs Q2
19,019
Shares Outstanding
freeFloat 100.00%
175,354
13F Shares Held
▼ 130,279 vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
PBM largest shareholders · institutional ownership
Q3 2025 · SEC 13F
Showing top 9 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
PARALLEL ADVISORS, LLC pharmaceutical preparations | 151.3K | 1.70% | 1.70% | $686.67M | Nov 13, 2025 | NEW |
VIRTU FINANCIAL LLC pharmaceutical preparations | 10.3K | 11.62% | 11.62% | $33.00M | Nov 14, 2025 | NEW |
ADVISORSHARES INVESTMENTS LLC pharmaceutical preparations | 5.4K | 6.05% | 6.05% | $17.21M | Nov 5, 2025 | ▲ 930 |
ADVISOR GROUP HOLDINGS, INC. pharmaceutical preparations | 4.5K | 5.06% | 5.06% | $14.36M | Nov 14, 2025 | NEW |
BANK OF AMERICA CORP /DE/ pharmaceutical preparations | 3.3K | 3.76% | 3.76% | $10.69M | Feb 3, 2026 | — held |
STONEHAGE FLEMING FINANCIAL SERVICES HOLDINGS LTD pharmaceutical preparations | 561 | 0.63% | 0.63% | $1.79M | Nov 3, 2025 | — held |
PARALLEL ADVISORS, LLC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 13, 2025 | EXIT |
UBS GROUP AG pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 13, 2025 | EXIT |
SABBY MANAGEMENT, LLC pharmaceutical preparations | 0 | 0.00% | 0.00% | $0 | Nov 14, 2025 | EXIT |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2025 vs prior quarter
Q3 2025
1
Increased
+930 shares3
New Positions
first time holders0
Decreased
−0 shares3
Sold Out
fully exitedNet shares change (top 50)
+930
+930 / −0
Net new holders
+1
3 new / 3 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
PBM insider trading · insider activity
Source: SEC Form 4
Recent Insider Transactions
Showing 10 most recent · Common Stock only
No recent insider transactions reported.
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Psyence Biomedical Ltd. (PBM) is primarily owned by institutional investors, who hold approximately 100.0% of total shares outstanding. Company insiders own approximately 0.00%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Psyence Biomedical Ltd. is PARALLEL ADVISORS, LLC, holding approximately 151,250 shares — equal to 1.70% of outstanding shares — as of September 30, 2025.
A total of 6 institutional investors currently hold PBM stock, with a combined institutional value of approximately $763,723 as of the most recent 13F filing period.
Frequently asked questions
PBM ownershipPsyence Biomedical Ltd. (PBM) is primarily owned by institutional investors, who hold approximately 100.0% of shares. The largest shareholder is PARALLEL ADVISORS, LLC with a 1.70% stake. Company insiders hold 0.00%. Data sourced from SEC Form 13F as of September 30, 2025.